Effective treatment of chronic illness resulting from the long-term buildup of heavy
metals in the body, such as chelation therapy, presents numerous clinical challenges, including
undesirable side effects and unpredictable efficacy. Use of a naturally occurring zeolite, clinoptilolite, to remove these toxic substances may offer an efficacious and safe alternative to the
traditional approaches. This study was designed to evaluate the ability of activated clinoptilolite
suspended in water (ACS) to remove heavy metals from the body through urinary excretion
without the undesirable removal of physiologically important electrolytes. The protocol utilized
two treatment groups, each consisting of eleven healthy men aged 36 to 70 years. Volunteers
were given a commercially available version of the study substance for seven days (Group 1)
and 30 days (Group 2) and urine samples were collected at specified time points in the study.
Changes in urinary concentration of the heavy metals were measured by inductively coupled
plasma mass spectrometry and compared to the baseline. Also, serum samples were obtained
from five individuals in each group and serum electrolytes were measured prior to and after
taking the product. Participants in both groups had increased concentrations of heavy metals
in the urine with the peak excretion at around day 4. No clinically significant alterations in
serum electrolyte levels were seen at either seven or 30 days on ACS. In conclusion, this study
demonstrates that the daily use of an activated clinoptilolite suspension represents a potentially
safe and effective way to remove toxic heavy metals from the body through increased urinary
excretion without removing clinically detrimental amounts of vital electrolytes.<\/p>\n\n\n\n